2.43 USD
↗ 1.03 (73.36%)PRE MARKET (AS OF 09:05 AM EDT)
Shares of Boundless Bio, Inc. Common Stock (BOLD) are trading at $2.43. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest BOLD is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Jun 22, 2026.